Use of Fluticasone Propionate/Salmeterol Combination Post Emergency Department Visit

• Status: Completed
• Trial end date: 2010-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The objective of this study is to compare readmission to the emergency department for asthma in asthma patients who receive treatment with fluticasone propionate and salmeterol oral inhaler after an initial emergency department visit using a retrospective observational cohort study design.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Fluticasone; Fluticasone Propionate, Salmeterol Xinafoate Drug Combination; Fluticasone-Salmeterol Drug Combination; Salmeterol Xinafoate; Xhance

Criteria

Inclusion Criteria:

• Subjects with asthma as determined by ICD-9 codes and asthma drug use

• at least 12 years of age

• discharged from an initial Emergency Department visit within 12 months

Exclusion Criteria:

• Subjects with COPD or treatment for COPD